Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 24, 2021
PerkinElmer announced documentation, workflow and decision-making Signals informatics platform is being expanded to build on existing capabilities in the biologics drug discovery space.
read more
Thursday, September 07, 2017
PerkinElmer expanded its Whole Genome Sequencing (WGS) services to families that preserve their cord blood and cord tissue with ViaCord.
read more
Wednesday, April 17, 2019
PerkinElmer announced it has joined Accenture’s open partner ecosystem, designed to help solution providers, software vendors and life sciences companies accelerate drug discovery.
read more
PerkinElmer announced the launch of PerkinElmer Genetics’ clinical genomics services.
read more
Friday, February 19, 2021
PerkinElmer launched the first cell painting kit as part of its new portfolio of PhenoVue cellular imaging reagents.
read more
Monday, February 01, 2021
PerkinElmer announced the addition of new assay kits to help further GPCR (G Protein-Coupled Receptor) therapeutic discovery.
read more
Wednesday, November 25, 2020
PerkinElmer has introduced the LC 300 platform and SimplicityChrom software.
read more
Monday, September 11, 2017
PerkinElmer has announced the launch of its QSight 210 MD system, designed to provide routine high throughput quantitation to laboratories.
read more
Monday, November 26, 2018
PerkinElmer announced its Vanadis NIPT system has obtained CE-IVD mark for commercialization and distribution throughout Europe and other countries that accept CE marking.
read more
PerkinElmer announced that it has entered into a definitive agreement to acquire Euroimmun Medical Laboratory Diagnostics AG.
read more
PerkinElmer announced a collaboration with Helix to develop and commercialize exome sequencing-based tests that will empower consumers to make proactive health management decisions.
read more
PerkinElmer announced a research team at NCATS is working with PerkinElmer’s AlphaLISA immunoassay to support the global search for effective COVID-19 therapeutics.
read more
Wednesday, August 07, 2019
Cambrex has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion, including Cambrex’s net debt.
read more
Permira, a global private equity firm, has announced that a company backed by the Permira funds has signed a definitive agreement to acquire Lyophilization Services of New England, Inc (“LSNE”), a contract development and manufacturing organization ...
read more
Quotient Sciences and Permira announced a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in Quotient.
read more